Difficulty: Medium
Average Score: 73%
Practice
Which of the following direct thrombin inhibitors is administered to clients having hip replacement surgery to prevent DVT?
Correct answer
A
Rationale
In the context of hematologic drugs and the prevention of deep vein thrombosis (DVT) in clients undergoing hip replacement surgery, the correct answer is A) Desirudin. Desirudin is a direct thrombin inhibitor that is specifically indicated for the prevention of DVT after hip replacement surgery.
Desirudin exerts its anticoagulant effects by directly inhibiting thrombin, a key enzyme in the clotting cascade. By inhibiting thrombin, Desirudin helps prevent the formation of blood clots in the veins, reducing the risk of DVT post-surgery.
Option B) Argatroban is also a direct thrombin inhibitor, but it is primarily used for patients with heparin-induced thrombocytopenia (HIT) or for anticoagulation in patients undergoing percutaneous coronary interventions. It is not the preferred choice for DVT prophylaxis in hip replacement surgery.
Option C) Dabigatran is a direct oral anticoagulant that works by inhibiting thrombin. However, it is not typically used for DVT prophylaxis in hip replacement surgery. Dabigatran is more commonly used for stroke prevention in patients with atrial fibrillation or for the treatment and prevention of venous thromboembolism.
Selecting the correct medication for a specific clinical scenario is crucial in ensuring optimal patient outcomes. Understanding the mechanisms of action, indications, and contraindications of different hematologic drugs is essential for healthcare professionals to make informed decisions in clinical practice and provide safe and effective care to their patients.
Desirudin exerts its anticoagulant effects by directly inhibiting thrombin, a key enzyme in the clotting cascade. By inhibiting thrombin, Desirudin helps prevent the formation of blood clots in the veins, reducing the risk of DVT post-surgery.
Option B) Argatroban is also a direct thrombin inhibitor, but it is primarily used for patients with heparin-induced thrombocytopenia (HIT) or for anticoagulation in patients undergoing percutaneous coronary interventions. It is not the preferred choice for DVT prophylaxis in hip replacement surgery.
Option C) Dabigatran is a direct oral anticoagulant that works by inhibiting thrombin. However, it is not typically used for DVT prophylaxis in hip replacement surgery. Dabigatran is more commonly used for stroke prevention in patients with atrial fibrillation or for the treatment and prevention of venous thromboembolism.
Selecting the correct medication for a specific clinical scenario is crucial in ensuring optimal patient outcomes. Understanding the mechanisms of action, indications, and contraindications of different hematologic drugs is essential for healthcare professionals to make informed decisions in clinical practice and provide safe and effective care to their patients.